Cervical Cancer PDX Models

Patient Derived Xenograft (PDX) models display a true representation of the human heterogeneity of gynecologic malignancies and provide the most accurate approach to predicting an agent’s efficacy prior to entering the clinic. The CrownBio cervical cancer PDX collection consists of several models, including models of North American and Asian descent, which are useful for screening novel therapies and potential biomarker discovery. More

Patient-derived xenografts (PDX) offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials.
CrownBio’s HuPrime® PDX collection well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL ID CANCER TYPE SUBTYPE models per page
CV10037 Cervical Cancer NEC VIEW MODEL Details
CV10040 Cervical Cancer NA VIEW MODEL Details
CV10045 Cervical Cancer NA VIEW MODEL Details
CV10054 Cervical Cancer NA VIEW MODEL Details
CV10058 Cervical Cancer NA VIEW MODEL Details
CV1248 Cervical Cancer SCC VIEW MODEL Details
CV1664 Cervical Cancer SCC VIEW MODEL Details
CV1802 Cervical Cancer SCC VIEW MODEL Details
CV2320 Cervical Cancer SCC VIEW MODEL Details
CV3035 Cervical Cancer SCC VIEW MODEL Details